TEAM

Investors seem to be suffering from a severe case of schizophrenia. Earlier in the week, work-from-home names heavily underperformed cyclical names, On Friday, investors seemed determined to erase that judgement. And indeed, one company whose management pointed out that it was concerned about the percentage growth of its Q4 backlog because of economic headwinds spawned…

To access this post, you must subscribe.

Read More

Summary Last week Atlassian announced results for its latest fiscal year that ended 6/30. The results unsurprisingly were another in a lengthy string of noticeable beats. Guidance was provided just for Q1 and it was essentially in line with prior estimates; full year guidance was not provided due to the lack of visibility. The company,…

To access this post, you must subscribe.

Read More

We are making the following changes in the high growth portfolio, effective today, July 23, 2020. We are selling an additional 125 shares of our Alteryx position at $171 which has yielded proceeds of $21,375 and we have sold 110 shares of our Atlassian position at $194.50 which has yielded proceeds of $21,395. The two…

To access this post, you must subscribe.

Read More

One subscriber wrote me that last week was a “hell of a week.” And so it was. I read a drumbeat of articles talking about bubbles and over-valuation. I have presented my thesis often enough. When I write articles and present investment ideas, I try to do so on the basis of logic and not…

To access this post, you must subscribe.

Read More

First, please accept my apologies regarding the lack of access many of you have had to the Ticker Target site the last few days. It was a priority to restore the service and we have it restored at this point. There are a couple of articles missing and they will be shortly restored as well.…

To access this post, you must subscribe.

Read More

Atlassian (TEAM) reported the results of its fiscal Q3 on Wednesday. April 17th. The results for the quarter handily surpassed prior guidance and the consensus expectations. The company’s forecast was said by the headlines to have been mixed. Not really, but the shares are down almost 10% in the wake of the earnings guide. So…

To access this post, you must subscribe.

Read More

Atlassian held its analyst day last week which was organized around it US user conference in Las Vegas. As most such gatherings, this one featured commentary about products, technology and the state of the market. Atlassian is scheduled to report its results next week, and I do not believe that the analyst meeting, long planned,…

To access this post, you must subscribe.

Read More

Atlassian-(TEAM) Yesterday, Atlassian reported another in a strong of what seem to be unusually strong quarters. I suppose if the quarters are all showing growth at elevated levels, then the levels that are being shown are really not elevated. In fact, it seems reasonable to assume, that Atlassian’s organic growth rate is probably higher than…

To access this post, you must subscribe.

Read More

Cognizant (CTSH) We are buying 200 shares of Cognizant (CTSH) in our income/stability portfolio, using up our cash balance, and a little more. We are buying the shares at a price of $64.63, the closing price on Monday, which will take $12,926. We had sold Cognizant shares back in August at $75/share in the wake…

To access this post, you must subscribe.

Read More

Rumors about Atlassian

This afternoon, in the midst of another woeful day for IT stocks, and for many other equities, Atlassian shares rallied quite sharply and finished up by a bit more than 1%. The cause of this performance were rumors that circulated regarding the potential for Google to buy Atlassian in order to find a way of…

To access this post, you must subscribe.

Read More